tiprankstipranks
Verastem exercises early option to license VS-7375 from GenFleet Therapeutics
PremiumThe FlyVerastem exercises early option to license VS-7375 from GenFleet Therapeutics
1M ago
Verastem Strengthens Financials and Partnerships for Drug Launch
Premium
Company Announcements
Verastem Strengthens Financials and Partnerships for Drug Launch
1M ago
Verastem price target raised to $16 from $13 at RBC Capital
Premium
The Fly
Verastem price target raised to $16 from $13 at RBC Capital
2M ago
3 Best Stocks to Buy Now, 12/31/2024, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 12/31/2024, According to Top Analysts
2M ago
Verastem announces FDA acceptance and Priority Review of NDA for Avutometinib
Premium
The Fly
Verastem announces FDA acceptance and Priority Review of NDA for Avutometinib
2M ago
Verastem jumps 50% to $5.50 on FDA priority review for Avutometinib
Premium
The Fly
Verastem jumps 50% to $5.50 on FDA priority review for Avutometinib
2M ago
Verastem cuts FY24 EPS view to $4.17-$4.23 from $4.25-$4.35, consensus $4.28
PremiumThe FlyVerastem cuts FY24 EPS view to $4.17-$4.23 from $4.25-$4.35, consensus $4.28
4M ago
Verastem reports Q3 EPS (60c), consensus (74c)
Premium
The Fly
Verastem reports Q3 EPS (60c), consensus (74c)
4M ago
Verastem completes rolling NDA submission to FDA for Avutometinib+Defactinib
Premium
The Fly
Verastem completes rolling NDA submission to FDA for Avutometinib+Defactinib
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100